help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on November 8, 2005
Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2005-1743
A more recent version of this article appeared on February 1, 2006
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
91/2/460    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wang, C.
Right arrow Articles by Swerdloff, R. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, C.
Right arrow Articles by Swerdloff, R. S.

Submitted on August 3, 2005
Accepted on November 1, 2005

Levonorgestrel Implants Enhanced the Suppression of Spermatogenesis by Testosterone Implants: Comparison between Chinese and Non-Chinese Men*

Christina Wang*, Xin Hai Wang, Anita L. Nelson, Ka Kui Lee, Yu Gui Cui, Jian Sun Tong, Nancy Berman, Leslie Lumbreras, Andrew Leung, Laura Hull, Sagar Desai, and Ronald S. Swerdloff

Division of Endocrinology, Department of Medicine, Obstetrics & Gynecology, Pediatrics, Harbor-UCLA Medical Center and Los Angeles Biomedical Research Institute, Torrance, California 90509, USA (CW, AN, KKL, NB, LL, AL, LH, SD, RSS), Jiangsu Family Planning Research Institute (XHW, JST), and the First Affiliated Hospital, Nanjing Medical University (YGC), Nanjing, Jiangsu 210036, China

* To whom correspondence should be addressed. E-mail: wang{at}labiomed.org.

Context: Previous male contraceptive studies showed that progestins enhance spermatogenesis suppression by androgens in men.

Objective: We compared the efficacy of spermatogenesis suppression by combination of levonorgestrel (LNG) with testosterone (T) implants to T implants alone in two different ethnic groups.

Design: Randomized trial in two centers with two treatment groups.

Settings: Academic Medical Center in the United States and Research Institute in China.

Participants: 40 non-Chinese and 40 Chinese healthy male volunteers.

Interventions: Subjects were randomized to receive four LNG implants together with four T implants (inserted on day 1 and week 15-18) vs. T implants alone for 30 weeks.

Main Outcome Measures: The primary endpoint compared the efficiency of suppression to severe oligozoospermia (1 x 106/ml) by LNG plus T implants vs. T implants alone. The secondary endpoint examined differences in spermatogenesis suppression between Chinese and non-Chinese subjects.

Results: LNG plus T implants caused more suppression of spermatogenesis to severe oligozoospermia in treatment period than T implants alone at both sites (P < 0.02). In Chinese men, severe oligozoospermia was achieved in over 90% of men in both treatment groups. Suppression to severe oligozoospermia was less in the non-Chinese men (59%) after T alone (P < 0.020); this difference disappeared with combined treatment (89%). T implant extrusion occurred in six men. Acne and increased hemoglobin were the most common adverse events.

Conclusion: T implants resulted in more pronounced spermatogenesis suppression in Chinese men. Addition of LNG implants to T implants enhanced the suppression of spermatogenesis in the treatment period in both Chinese and non-Chinese men.


Key words: male contraception • testosterone implants • levonorgestrel implants




This article has been cited by other articles:


Home page
Endocr. Rev.Home page
S. T. Page, J. K. Amory, and W. J. Bremner
Advances in Male Contraception
Endocr. Rev., June 1, 2008; 29(4): 465 - 493.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. Wang, Y.-G. Cui, X.-H. Wang, Y. Jia, A. Sinha Hikim, Y.-H. Lue, J.-S. Tong, L.-X. Qian, J.-H. Sha, Z.-M. Zhou, et al.
Transient Scrotal Hyperthermia and Levonorgestrel Enhance Testosterone-Induced Spermatogenesis Suppression in Men through Increased Germ Cell Apoptosis
J. Clin. Endocrinol. Metab., August 1, 2007; 92(8): 3292 - 3304.
[Abstract] [Full Text] [PDF]


Home page
J AndrolHome page
A. Qoubaitary, C. Meriggiola, C. M. Ng, L. Lumbreras, S. Cerpolini, G. Pelusi, P. D. Christensen, L. Hull, R. S. Swerdloff, and C. Wang
Pharmacokinetics of Testosterone Undecanoate Injected Alone or in Combination With Norethisterone Enanthate in Healthy Men
J Androl, November 1, 2006; 27(6): 853 - 867.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2005 by The Endocrine Society